Marcusaurelius, you are right about the first two gross mistakes, but there is a third which is just as important.
3) You can't continue to make investors victims of unfullfilled expectations and expect to go back to the well for new funding without a cost. Let us hope that CYGX can go on and produce the science required for success, but let us also hope that they can find their way to sound financial management, which they have not had to date. A partnership with big pharma or a venture capital group that would ensure our longevity would be great, even with a big dilution at this point. I'll take half a loaf of something (as opposed to zip) as long as it gets us to the right end. And by the way, the big picture is not clear here for many, thus the busy board. Take care.
